Mori Tetsuya, Takimoto Tetsuya, Katano Naoyuki, Kikuchi Akira, Tabuchi Ken, Kobayashi Ryoji, Ayukawa Hiroshi, Kumagai Masa-aki, Horibe Keizo, Tsurusawa Masahito
Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.
Br J Haematol. 2006 Mar;132(5):594-7. doi: 10.1111/j.1365-2141.2005.05910.x.
This report presents a retrospective study of 26 Japanese children with recurrent anaplastic large cell lymphoma. The first relapses were documented at a median of 10.5 months after the initial diagnosis. Twenty-four patients achieved a second remission. After a median follow-up period of 47 months, 18 patients are still alive: 15 patients are in second complete remission (CR), three patients are in third CR or later. The 5 year overall and relapse-free survival rates were 61 +/- 12% and 51 +/- 12% respectively. The patients who received allogeneic haematopoietic stem cell transplantation during second CR showed a superior outcome to other patients.
本报告呈现了一项对26例复发性间变性大细胞淋巴瘤日本儿童的回顾性研究。首次复发记录于初始诊断后的中位时间10.5个月。24例患者实现了第二次缓解。经过中位47个月的随访期后,18例患者仍存活:15例患者处于第二次完全缓解(CR),3例患者处于第三次CR或更晚。5年总生存率和无复发生存率分别为61±12%和51±12%。在第二次CR期间接受异基因造血干细胞移植的患者比其他患者显示出更好的预后。